IL6 and COVID-19: Disruption of the integrity of tight junctions in between enterocytes of the gut called “leaky gut” in COVID-19 patients is responsible for the development of diarrhea, and inflammation due to higher levels of IL-6 in plasma and fecal calprotectin.